Dysregulation of Glutamate Carboxypeptidase II in Psychiatric Disease

Experimental evidence is beginning to converge on an important role for dysregulation of glutamate carboxypeptidase II (GCPII) in schizophrenia. The goal of this study was to determine GCPII levels in postmortem brain specimens of patients with schizophrenia, bipolar disorder or unipolar depression...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Guilarte, Tomás R., Hammoud, Dima A., McGlothan, Jennifer L., Caffo, Brian S., Foss, Catherine A., Kozikowski, Alan P., Pomper, Martin G.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2008
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2287371/
https://ncbi.nlm.nih.gov/pubmed/18191545
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.schres.2007.11.013
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak